In the BioHarmony Drug Report Database
Accolate (zafirlukast) is a small molecule pharmaceutical. Zafirlukast was first approved as Accolate on 1996-09-26. It is used to treat asthma in the USA. The pharmaceutical is active against cysteinyl leukotriene receptor 1. In addition, it is known to target cysteinyl leukotriene receptor 2, bifunctional epoxide hydrolase 2, and peroxisome proliferator-activated receptor gamma.
Image (chem structure or protein)